1. Home
  2. TXRH vs ICLR Comparison

TXRH vs ICLR Comparison

Compare TXRH & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXRH
  • ICLR
  • Stock Information
  • Founded
  • TXRH 1993
  • ICLR 1990
  • Country
  • TXRH United States
  • ICLR Ireland
  • Employees
  • TXRH N/A
  • ICLR N/A
  • Industry
  • TXRH Restaurants
  • ICLR Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • TXRH Consumer Discretionary
  • ICLR Health Care
  • Exchange
  • TXRH Nasdaq
  • ICLR Nasdaq
  • Market Cap
  • TXRH 12.6B
  • ICLR 11.6B
  • IPO Year
  • TXRH 2004
  • ICLR 1998
  • Fundamental
  • Price
  • TXRH $188.20
  • ICLR $150.41
  • Analyst Decision
  • TXRH Buy
  • ICLR Buy
  • Analyst Count
  • TXRH 21
  • ICLR 12
  • Target Price
  • TXRH $192.52
  • ICLR $187.82
  • AVG Volume (30 Days)
  • TXRH 1.1M
  • ICLR 1.1M
  • Earning Date
  • TXRH 08-07-2025
  • ICLR 07-23-2025
  • Dividend Yield
  • TXRH 1.45%
  • ICLR N/A
  • EPS Growth
  • TXRH 30.91
  • ICLR 11.53
  • EPS
  • TXRH 6.48
  • ICLR 9.19
  • Revenue
  • TXRH $5,499,763,000.00
  • ICLR $8,192,621,999.00
  • Revenue This Year
  • TXRH $11.22
  • ICLR N/A
  • Revenue Next Year
  • TXRH $8.90
  • ICLR $2.10
  • P/E Ratio
  • TXRH $29.03
  • ICLR $16.55
  • Revenue Growth
  • TXRH 15.09
  • ICLR N/A
  • 52 Week Low
  • TXRH $148.73
  • ICLR $125.10
  • 52 Week High
  • TXRH $206.04
  • ICLR $347.72
  • Technical
  • Relative Strength Index (RSI)
  • TXRH 48.85
  • ICLR 57.67
  • Support Level
  • TXRH $184.72
  • ICLR $146.56
  • Resistance Level
  • TXRH $189.30
  • ICLR $155.90
  • Average True Range (ATR)
  • TXRH 4.11
  • ICLR 4.88
  • MACD
  • TXRH -0.46
  • ICLR 0.23
  • Stochastic Oscillator
  • TXRH 53.89
  • ICLR 57.80

About TXRH Texas Roadhouse Inc.

Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.

About ICLR ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Share on Social Networks: